(Q34995996)

5 August 2017

1 reference

title

Late effects of childhood cancer therapy. (English)

1 reference

5 August 2017

1 reference

1

Debra L Friedman

1 reference

5 August 2017

Anna T Meadows

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Pediatric Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

49

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

1083-106, x

1 reference

Care and treatment of long-term survivors of childhood cancer

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Long-term survivors of childhood cancer. The medical consequences of cure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Late effects of childhood cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Long term survivors of childhood leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Symptoms of posttraumatic stress in young adult survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and d

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Visual and verbal short-term memory deficits in childhood leukemia survivors after intrathecal chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Academic career after treatment for acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Parental report of everyday cognitive abilities among children treated for acute lymphoblastic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Cancer in adolescents and young adults psychosocial aspects. Long-term survivors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Psychologic adaptation of survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Surviving cancer competently intervention program (SCCIP): a cognitive-behavioral and family therapy intervention for adolescent survivors of childhood cancer and their families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Anthracycline-induced cardiotoxicity in children and young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Increased risk of cardiac dysfunction after anthracyclines in girls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Pulmonary function after treatment for acute lymphoblastic leukaemia in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Morphologic and morphometric evaluation of the effect of ICRF-187 on bleomycin-induced pulmonary toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Properties and products of the degradation of DNA by bleomycin and iron(II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Thyroid dysfunction after radiotherapy in children with Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Endocrine late effects among survivors of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Hypothalamic-pituitary dysfunction after radiation for brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Precocious or early puberty and growth failure in girls treated for acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Cranial irradiation and early puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Relationship of growth hormone deficiency and leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Male reproductive function in long-term survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

The effects of etoposide on testicular function in boys treated for Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Gonadal function following chemotherapy for childhood Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Gonadal function following ABVD therapy for Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Female Reproductive Potential after Treatment for Hodgkin's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Prospects for fertility after chemotherapy or radiation for neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Pregnancy outcome in patients treated for Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Fertility and pregnancy after treatment for cancer during childhood or adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Reproduction post-chemotherapy in young cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Cryopreservation of semen from pubertal boys with cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Semen banking in patients with cancer: 20-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Investigation of fertilizing capacity of cryopreserved spermatozoa from patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Reproductive technologies 1998: options available for the cancer patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Ovarian tissue cryopreservation for patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Gonadal cryopreservation in the young patient with gynaecological malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

The cryopreservation of ovarian tissue as a strategy for preserving the fertility of cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Growth and final height after treatment for childhood Hodgkin disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Radiation induced height impairment in pediatric Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Stature loss following skeletal irradiation for childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Stature loss following treatment for Wilms tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Osteopenia in young adult survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

The effect of chemotherapy on the growing skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Bony morbidity in children treated for acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Osteoporosis: gender differences and similarities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Second cancers following pediatric Hodgkin's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Breast cancer and other second neoplasms after childhood Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Second malignant neoplasms in children: an update from the Late Effects Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Li-Fraumeni syndrome--a molecular and clinical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Hepatoblastoma and familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

SIOP Working Committee on psychosocial issues in pediatric oncology: guidelines for communication of the diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement Section on Hematology/Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Feasibility of implementing health promotion interventions to improve health-related quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Breast cancer screening in childhood cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Mammographic screening of the high-risk woman.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Breast masses in women treated for childhood cancer: incidence and screening guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Transitions in the care of adolescent and young adult survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Social maturation. A challenge for handicapped and chronically ill adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Transition to adult health care: Setting the stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Pediatric nurse practitioners specializing with survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Longitudinal evaluation of cardiopulmonary performance during exercise after bone marrow transplantation in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Retaining and tracking cohort study members.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Response bias and risk ratios in epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

The effects of non-response in a prospective study of cancer: 15-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Programs for adult survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms' tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Attitudes and beliefs of African Americans toward participation in medical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Issues in the consideration of intervention strategies in long-term survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

A comparison of responses to mailed questionnaires and telephone interviews in a mixed mode health survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Response rates to mail surveys published in medical journals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

A comparison of costs and data quality of three health survey methods: mail, telephone and personal home interview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Methods for tracing, contacting, and recruiting a cohort of survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

A methodological framework for assessing health indices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Exposure measurement in cohort studies: the challenges of prospective data collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Recall bias in epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Comparative measurement sensitivity of short and longer health status instruments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Late effects of treatment for Wilms tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: a report from the National Wilms Tumor Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

The Childhood Cancer Survivor Study: an important research initiative for childhood cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Marriage in the survivors of childhood cancer: a preliminary description from the Childhood Cancer Survivor Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Validation of self-reported complications by bone marrow transplantation survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

The pediatric cancer quality of life inventory-32 (PCQL-32): I. Reliability and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

7 January 2021

Coronary artery disease mortality in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

7 January 2021

Advances in the treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

7 January 2021

Life beyond pediatrics. Transition of chronically ill adolescents from pediatric to adult health care systems

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

7 January 2021

Gaining and sustaining minority participation in longitudinal research projects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

7 January 2021

Barriers to the use of health status measures in clinical investigation, patient care, and policy research

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

7 January 2021

Posttraumatic stress, family functioning, and social support in survivors of childhood leukemia and their mothers and fathers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900032-9

7 January 2021

10.1016/S0031-3955(02)00032-9

Identifiers

DOI

1 reference

5 August 2017

1 reference